Polymer-drug conjugates (PDCs) are drug delivery systems where one or more drug (s) are
covalently attached to the functional groups of the polymer directly or through a spacer …

Polymeric drug conjugates (PDCs) for cancer therapy have been a hot research topic for the
past three decades. Successful examples of PDC conjugates have demonstrated sustained …

Drug delivery systems for cancer therapeutics have revolutionized medicine. Delivery
systems have improved the efficacy and reduced the toxicity of current therapies and …

Polymer–drug conjugates (PDCs) have shown great promise in enhancing the efficacy and
safety of cancer therapy. These conjugates combine the advantageous properties of both …

The combination of polymer technology and targeted drug delivery may pave the way for
more effective yet safer therapeutic options for cancer therapy. Polymer-drug conjugates …

Cancer is the second worldwide cause of death following cardiovascular diseases.
Chemotherapy is the gold standard strategy for effective treatment of cancer. However, the …

Use of polymeric drug delivery systems is rapidly becoming an established approach for
improvement of cancer chemotherapy. Zoladex (R), a poly lactide-co-glycolide …

Drug Delivery in Oncology: From Basic Research to Cancer Therapy: Design of Polymerâ•’Drug
Conjugates Page 1 483 Polymer-Based Systems Drug Delivery in Oncology: From Basic …

The majority of anti-cancer drugs show poor water solubility and produce adverse effects in
healthy tissue. The combination of polymer technology and targeted drug delivery system …

Objective: Clinical proof of concept for polymer conjugates has already been achieved over
the last 30 years, with a family of polymer–protein conjugates reaching the market and an …